To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization
Leisha Kopp, Mason Bonitz
Transforming viral vector manufacturing with next-generation CGMP plasmids platform
John Bowen, Brian Tomkowicz
GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing
Lili Belcastro, Basak Clements, Claire Wartel
Advancing AAV manufacturing: strategic insights and cost-effective solutions for the future of gene therapies
Michael DiBiasio-White, Ying Cai, Roland Pach
Preserving the future of medicine: standardizing leukapheresis materials with cryopreservation for scalable cell therapies
R Luke, M Giedlin, D Clarke et al
When does outsourcing autologous collection center qualification and the cell therapy supply chain make sense?
Amy Hines, Jeni Newman, Marcel van Houten
Understanding and leveraging cord blood bank capabilities and practices in cell therapy development
J Aho, A Conerty, S Shields et al